[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100421079":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":59,"collaborators":11,"id":63,"slug":11,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":11,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":11,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Cedars-Sinai Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Whole-Body Magnetic Resonance Imaging","EXPERIMENTAL",null,[13],"Other: Whole-body Magnetic Resonance Imaging",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"Whole-body Magnetic Resonance Imaging","Whole-body Magnetic Resonance Imaging at baseline, 1 month, and 12 months",[9],[20],{"name":21,"affiliation":5,"role":22},"Nicole Baca, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Clinical Trial Recruitment Navigator","CONTACT","3104232133","GroupCancerTrialInformation@cshs.org",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Cedars Sinai Medical Center","RECRUITING","Los Angeles","California","90048","United States",{"type":38,"coordinates":39},"Point",[40,41],-118.24368,34.05223,{"lat":41,"lon":40},[44,46,49,51,53,55,57],{"name":25,"role":26,"phone":45,"phoneExt":11,"email":28},"310-423-2133",{"name":47,"role":48,"phone":11,"phoneExt":11,"email":11},"Fataneh Majlessipour, MD","SUB_INVESTIGATOR",{"name":50,"role":48,"phone":11,"phoneExt":11,"email":11},"Pedro Sanchez, MD, MSCE",{"name":52,"role":48,"phone":11,"phoneExt":11,"email":11},"Edwin Posadas, MD",{"name":54,"role":48,"phone":11,"phoneExt":11,"email":11},"Debiao Li, PhD",{"name":56,"role":48,"phone":11,"phoneExt":11,"email":11},"Yibin Xie, PhD",{"name":58,"role":48,"phone":11,"phoneExt":11,"email":11},"Touseef Qureshi, PhD",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Nicole Baca","Assistant Professor of Department of Pediatrics","100421079",false,"NCT04763109","Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence","Inclusion Criteria:\n\n* Between the ages of 5 and \\\u003C18 years at the start of study. If subject will turn 18 during the study, they will be allowed to enroll.\n* Clinically or molecularly confirmed diagnosis of NF-1. Subjects with mosaic\u002Fsegmental NF-1 also qualify for the study.\n\nExclusion Criteria:\n\n* Requiring sedation for imaging.\n* Implants and\u002For Devices: Mechanical, magnetic or electrical activated implants; Ferromagnetic implants and foreign bodies\n* Claustrophobia, problems being in enclosed spaces, or inability to lie facing upwards.\n* Allergy to animal dander or animal-instigated asthma.","ALL","5 Years","17 Years",{"count":72,"type":73},15,"ESTIMATED","INTERVENTIONAL",[76],"NA","This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.",[79],"Neurofibromatosis Type 1",[81,79,82],"Pediatric","magnetic resonance imaging","2026-05-01",{"date":85,"type":86},"2026-05-07","ACTUAL",{"date":88,"type":86},"2022-07-08",{"date":90,"type":73},"2029-05",{"name":61,"class":6},1]